Search clinical trials for: Aromatase inhibitor or fulvestrant
Total 233738 results
-
AstraZenecaNot yet recruiting
-
The Affiliated Hospital of Qingdao UniversityNot yet recruitingNeoplasms | Breast Cancer | Breast DiseasesChina
-
BeiGeneRecruitingBreast Cancer | Metastatic Breast Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | Hormone Receptor Positive Malignant Neoplasm of Breast | HER2-negative Breast Cancer | Hormone-receptor-positive Breast CancerChina
-
University of WashingtonBreast Cancer Research FoundationNot yet recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic HER2-Negative Breast Carcinoma | Metastatic Hormone Receptor-Positive Breast Carcinoma | Locally Advanced Unresectable HER2-Negative Breast Carcinoma | Locally Advanced Unresectable Hormone Receptor-Positive...United States
-
BeiGeneRecruitingAdvanced Breast Cancer | Metastatic Breast Cancer | Advanced Solid Tumor | Non-small Cell Lung Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast Cancer | Hormone-receptor-positive...Australia, United States
-
PfizerRecruitingAdvanced or Metastatic Breast CancerUnited States, Israel, Taiwan, Argentina, Japan, Korea, Republic of, Canada, Australia, Brazil
-
Olema Pharmaceuticals, Inc.RecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | HER2 Negative Breast Carcinoma | ER Positive Breast CancerUnited States, Korea, Republic of, Australia, Taiwan, Hong Kong, Malaysia, Thailand, Argentina, Belgium, Portugal, Italy
-
Fudan UniversityRecruitingBreast Cancer | Advanced Breast CancerChina
-
Tianjin Medical University Cancer Institute and...RecruitingHR Positive HER2 Negative Advanced Breast CancerChina
-
Avenzo Therapeutics, Inc.Recruiting
-
University of MiamiRecruitingBreast Cancer | Metastatic Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
Novartis PharmaceuticalsRecruiting
-
Fudan UniversityChongqing University Cancer Hospital; Sun Yat-sen University; Peking University... and other collaboratorsRecruitingBreast Cancer | Advanced Breast Cancer | Breast Neoplasm | HER2-negative Breast Cancer | Hormone Receptor Positive TumorChina
-
University of California, IrvineRecruitingBreast Cancer | Metastatic Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor-positive Breast CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterRecruitingQuality of Life | Breast CancerUnited States
-
Oana DanciuNovartis PharmaceuticalsRecruitingHER2-negative Breast Cancer | Locoregional Recurrence | Hormone Receptor-positive Breast CancerUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu HengRui Medicine Co., Ltd.RecruitingMetastatic Breast CancerChina
-
wang shusenRecruiting
-
Prof. Wolfgang JanniEli Lilly and CompanyRecruitingHormone Receptor-positive Metastatic Breast Cancer | HER2-negative Metastatic Breast CancerGermany, Switzerland
-
Eli Lilly and CompanyLoxo Oncology, Inc.RecruitingBreast CancerUnited States, Spain, Korea, Republic of, China, France, Germany, Japan, Belgium, Italy, Australia, United Kingdom, Canada, Singapore
-
Genentech, Inc.RecruitingEstrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast CancerKorea, Republic of, United States, Spain, Taiwan, United Kingdom, Japan, Germany, Argentina, Turkey, Greece, Italy, Singapore, South Africa
-
The Methodist Hospital Research InstituteEli Lilly and CompanyRecruitingHER2-negative Breast Cancer | ER-Positive Breast CancerUnited States
-
PfizerRecruitingBreast Cancer | Solid TumorsChina, United States, Mexico, Bulgaria, Spain, Brazil, Czechia, Argentina, South Africa
-
PfizerRecruitingBreast Cancer | Head and Neck CancerKorea, Republic of, Mexico, Ukraine, United States
-
SOLTI Breast Cancer Research GroupNovartis; Alliance Foundation Trials, LLC.RecruitingMetastatic Breast CancerUnited States, Spain, Portugal
-
National University Hospital, SingaporeEisai Co., Ltd.Recruiting
-
Novartis PharmaceuticalsRecruitingMetastatic Breast CancerUnited States, Lebanon, Hong Kong, Turkey, Vietnam, Brazil, Italy, South Africa, Korea, Republic of, Poland, Taiwan, Singapore, Japan, Spain, Costa Rica, Greece, Portugal, Argentina, Mexico
-
Novartis PharmaceuticalsRecruitingBreast CancerGermany, Italy, Belgium, Denmark, France, Spain, Finland, Hungary, Ireland, Czechia, Greece, Canada, Portugal, Slovakia, Bulgaria, Poland, Romania
-
Ahon Pharmaceutical Co., Ltd.Affiliated Hospital of Hebei University; The First Hospital of Jilin University and other collaboratorsRecruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHormone Receptor Positive Advanced Breast CancerChina
-
Royal Marsden NHS Foundation TrustPfizer; AstraZeneca; Institute of Cancer Research, United Kingdom; UNICANCER; Gustave... and other collaboratorsRecruitingHER2-negative Breast Cancer | ER+ Breast CancerUnited Kingdom, France
-
Eli Lilly and CompanyRecruitingBreast Neoplasms | Neoplasm MetastasisJapan, United States, China, Czechia, Belgium, Brazil, Germany, Netherlands, Russian Federation, Ukraine, Taiwan, France, Korea, Republic of, Italy, Spain, Australia, Turkey, India, Argentina, Greece, Austria, Mexico
-
Haihe Biopharma Co., Ltd.Not yet recruiting
-
Blokhin's Russian Cancer Research CenterRecruitingBreast Cancer Stage IVRussian Federation
-
Marina N SharifiNovartis; University of Wisconsin, MadisonRecruitingHormone Receptor Positive Breast Carcinoma | HER2-negative Breast Cancer | PIK3CA Mutant Metastatic Breast CancerUnited States
-
PfizerRecruitingLocally Advanced or Metastatic ER+ HER2- Breast Cancer | Locally Advanced or Metastatic Castration-resistant Prostate Cancer | Locally Advanced or Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Korea, Republic of, Japan
-
PfizerRecruitingBreast Neoplasms | Prostate Cancer | Adenocarcinoma of Lung | Solid Tumors | Liposarcoma | CRCChina, United States, United Kingdom, Mexico, Czechia, Japan, Slovakia, Argentina
-
MedSIRNovartisRecruiting
-
Beta Pharma (Suzhou) Co., Ltd.RecruitingAdvanced Solid Tumor | HR+/HER2- Breast CancerChina
-
UNICANCERRecruiting
-
German Breast GroupPfizer; AMS Advanced Medical Services GmbHRecruitingMetastatic Breast CancerGermany
-
Lund University HospitalSouth Sweden Breast Cancer GroupRecruiting
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingStage IV Breast Cancer AJCC v6 and v7 | Metastatic Breast CarcinomaUnited States
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)RecruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | HER2/Neu Negative | Estrogen Receptor and/or Progesterone Receptor PositiveUnited States
-
Washington University School of MedicineGenomic Health®, Inc.RecruitingBreast Cancer | Breast Neoplasms | Cancer of Breast | Cancer of the BreastUnited States
-
Prof. W. JanniRoche Pharma AG; Novartis Pharmaceuticals; Celgene Corporation; Eisai GmbHRecruiting
-
PfizerActive, not recruitingBreast Cancer | Small Cell Lung Cancer | Ovarian CancerUnited States, China, Japan, Mexico, Bulgaria, Argentina
-
Priscilla McAuliffeActive, not recruiting
-
Canadian Cancer Trials GroupHoffmann-La RocheActive, not recruiting
-
Tvardi Therapeutics, IncorporatedActive, not recruiting